11 Oncology Genetic Tests Advancements Set for 2026
Liquid Biopsies and Minimal Residual Disease Detection Oncology genetic tests in 2026 have been revolutionized by the clinical validation of liquid biopsies for early cancer detection. These non-invasive tests can identify genetic mutations in circulating tumor DNA with such precision that they can detect potential malignancies years before they appear on a CT scan. This breakthrough is...
0 Commentarios 0 Acciones 4 Views 0 Vista previa